JULY 3-9, 2026
Swiss pharmaceuticals giant Roche continues an expansion project at its Indianapolis-based diagnostics unit as it awaits U.S. regulatory approval for a new diabetes treatment. Daniel Bradley has the latest on the $550 million investment. Also in this week’s issue, Susan Orr reports that local nonprofits and wealth managers are seeing a growing interest in charitable gifts that are distributed from an estate after a donor’s death. And Dave Lindquist explains how two local teenagers are building careers in the music business.